Levetiracetam
Product Images NDC 60432-831

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 60432-831). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Morton Grove Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

27944da6 Ecc6 4d33 90c3 1f9519cbc5fe 01

This text seems to be instructions for calculating a patient's total daily dose based on their weight and a given daily dose in milligrams per kilogram. The final line provides the concentration of whatever medication is being used at 100 milligrams per milliliter.*

FDA Label Image

27944da6 Ecc6 4d33 90c3 1f9519cbc5fe 02

This text provides formulas to calculate estimated glomerular filtration rate (eGFR) using age, weight, and serum creatinine. The formula differs slightly for female patients, as noted by the multiplication by 0.85.*

FDA Label Image

27944da6 Ecc6 4d33 90c3 1f9519cbc5fe 03

The text appears to be partially unreadable or corrupted. The characters do not form a coherent description. Therefore, it is not possible to provide a useful description with this text.*

FDA Label Image

27944da6 Ecc6 4d33 90c3 1f9519cbc5fe 04

FDA Label Image

27944da6 Ecc6 4d33 90c3 1f9519cbc5fe 05

This text is a table showing percentages of different dosages of Levetiracetam compared to a Placebo. The percentages are 39.6%, 37.1%, and 7.4%. There is also information about the sample size for each group.*

FDA Label Image

27944da6 Ecc6 4d33 90c3 1f9519cbc5fe 06

This is a report of the percentages of three drugs, Levetiracetam, Loveliracetam and a Placebo, with their corresponding dosage (1000 mg/day and 2000 mg/day) in a certain experiment. The numbers 35.2%, 20.8% and 6.3% probably refer to the efficacy rates of the three drugs in the experiment. There were 105 participants in the study. The context and purpose of the experiment are not given.*

FDA Label Image

27944da6 Ecc6 4d33 90c3 1f9519cbc5fe 07

This appears to be a medical study that may be reporting the results of a clinical trial. However, without additional information, it is difficult to determine the specific findings or purpose of the study.*

FDA Label Image

27944da6 Ecc6 4d33 90c3 1f9519cbc5fe 08

This text appears to be presenting some statistical data. There are three columns with percentages listed, however, there is no information in the context to identify what the percentages represent. The first two percentages are followed by blank spaces, so it is unclear if there is supposed to be additional information or data listed. The last two rows contain the names of two groups, the Placebo group with a sample size of 7 and the Levetiracetam group with a sample size of 101. Without further context or information, it is difficult to determine the purpose or implications of this data.*

FDA Label Image

27944da6 Ecc6 4d33 90c3 1f9519cbc5fe 09

This appears to be a table containing percentages for two groups of individuals treated with either Placebo or Levetiracetam. However, without additional information or context it is not clear what the percentages represent.*

FDA Label Image

27944da6 Ecc6 4d33 90c3 1f9519cbc5fe 10

This is a table showing the percentage of patients in a clinical study who were either given a placebo or Levetiracetam. The percentages of patients given each treatment are 10%, 45.2%, and 72.2%, but it is not clear what these percentages represent. The study included 64 patients who received a placebo and 79 patients who received Levetiracetam.*

FDA Label Image

27944da6 Ecc6 4d33 90c3 1f9519cbc5fe 11

This is a medication called Leviracetam Oral Solution with a concentration of 100mg/mL, manufactured by Morton Grove Pharmaceuticals in Morton Grove, IL. It is distributed by Wockhardt USA LLC in Parsippany, NJ. The solution should be stored in a temperature range of 15°C to 30°C and kept out of reach of children. The package insert provides complete dosage instructions. The medication should be dispensed in a tight, light-resistant container with a child-proof cap. The package contains 16 fl oz (473 mL) of the solution. The text includes a warning not to use the medication if the tamper-evident seal is missing or broken.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.